These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9578722)

  • 1. [Multifactorial model of estrogen synthesis in tumor tissue of breast cancer].
    Berstein LM
    Vopr Onkol; 1998; 44(1):7-11. PubMed ID: 9578722
    [No Abstract]   [Full Text] [Related]  

  • 2. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
    Sonne-Hansen K; Lykkesfeldt AE
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
    Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of aromatase expression in breast cancer tissue.
    Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
    Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
    Rubin GL; Zhao Y; Kalus AM; Simpson ER
    Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aromatase--key enzyme of estrogen biosynthesis].
    Milczarek R; Klimek J
    Postepy Biochem; 2005; 51(4):430-9. PubMed ID: 16676578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Potential for using aromatase inhibitors for preventing breast cancer].
    Santen RJ
    Vopr Onkol; 2001; 47(2):187-94. PubMed ID: 11383455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aromatase and breast cancer].
    Miller WR; Howie F; Mason I
    Vopr Onkol; 2001; 47(2):182-6. PubMed ID: 11383454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase inhibitors: new endocrine treatment of breast cancer.
    Brueggemeier RW
    Semin Reprod Med; 2004 Feb; 22(1):31-43. PubMed ID: 15083379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
    Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
    Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatase in the context of breast and endometrial cancer. A review.
    Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ
    Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective spatial upregulation of intratumoral stromal aromatase in breast cancer patients: evidence for imbalance of local estrogen metabolism.
    Singer CF; Fink-Retter A; Gschwantler-Kaulich D; Thalhammer T; Hudelist G; Mueller R; Czerwenka K; Kubista E
    Endocr Relat Cancer; 2006 Dec; 13(4):1101-7. PubMed ID: 17158756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid metabolism in breast cancer.
    Foster PA
    Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.
    Miki Y; Suzuki T; Tazawa C; Yamaguchi Y; Kitada K; Honma S; Moriya T; Hirakawa H; Evans DB; Hayashi S; Ohuchi N; Sasano H
    Cancer Res; 2007 Apr; 67(8):3945-54. PubMed ID: 17440110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase inhibitors in breast cancer.
    Hiscox S; Davies EL; Barrett-Lee P
    Maturitas; 2009 Aug; 63(4):275-9. PubMed ID: 19577386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells.
    Gonzalez A; Cos S; Martinez-Campa C; Alonso-Gonzalez C; Sanchez-Mateos S; Mediavilla MD; Sanchez-Barcelo EJ
    J Pineal Res; 2008 Aug; 45(1):86-92. PubMed ID: 18298468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.
    Bulun SE; Lin Z; Imir G; Amin S; Demura M; Yilmaz B; Martin R; Utsunomiya H; Thung S; Gurates B; Tamura M; Langoi D; Deb S
    Pharmacol Rev; 2005 Sep; 57(3):359-83. PubMed ID: 16109840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organization of the human aromatase p450 (CYP19) gene.
    Bulun SE; Takayama K; Suzuki T; Sasano H; Yilmaz B; Sebastian S
    Semin Reprod Med; 2004 Feb; 22(1):5-9. PubMed ID: 15083376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin modulates aromatase activity in MCF-7 human breast cancer cells.
    Cos S; Martínez-Campa C; Mediavilla MD; Sánchez-Barceló EJ
    J Pineal Res; 2005 Mar; 38(2):136-42. PubMed ID: 15683469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.